臺灣核心實作指引(TW Core IG)
0.3.1 - Ci-Build Trial Use

臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions

Example QuestionnaireResponse: 問卷題目回覆

Generated Narrative: QuestionnaireResponse qr-example

LinkIDTextDefinitionAnswerdoco
.. qr-exampleQuestionnaire:Medication or Other Substance
... Medication/header
.... 0Form ID:000
.... 74080-3/74081-1Event ID:456
.... 74080-3/30947-6Initial Report Date (HERF Q1)2016-03-14
... Medication/SEC00Medication or Other Substance
.... Medication/SEC01/74080-3
..... 74080-3/74076-1What type of medication/substance was involved?LOINC LA20271-5: Medications
...... 74080-3/74075-3What type of medication?LOINC LA20278-0: Prescription or over-the-counter (including herbal supplements)
..... 74080-3/74072-0Which of the following best characterizes the event?LOINC LA20275-6: Incorrect action (process failure or error) (e.g., such as administering overdose or incorrect medication)
..... 74080-3/74071-2What was the incorrect action?LOINC LA20276-4: Incorrect patient
..... 74080-3/74063-9At what stage in the process did the event originate, regardless of the stage at which it was discovered?LOINC LA20296-2: Administering
.... 74080-3/74078-7
..... 74080-3/74078-7/74062-1Generic name or investigational drug nameAcetaminophen
..... 74080-3/74078-7/74055-5Dosage form of ProductTablet
..... 74080-3/74078-7/74053-0Was this medication/substance prescribed for this patient?LOINC LA32-8: No
..... Medication/74052-2Was this medication/substance given to this patient?LOINC LA33-6: Yes

doco Documentation for this format